- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. To schedule a demo, contact us at sales@docketalarm.com or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 54-68 of
1,262 results
9 Notice Notice filing date accorded: Notice Notice filing date accorded
Document
IPR2024-00107, No. 9 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Nov. 29, 2023)
|
|
Cite Document
11 Order Other: SCHEDULING ORDER
Document
IPR2023-00724, No. 11 Order Other - SCHEDULING ORDER (P.T.A.B. Oct. 4, 2023)
|
|
Cite Document
10 Institution Decision Grant: Institution Decision Grant
Document
IPR2023-00724, No. 10 Institution Decision Grant - Institution Decision Grant (P.T.A.B. Oct. 4, 2023)
|
|
Cite Document
20 Motion Other: Patent Owners Motion to Seal
Document
IPR2024-00631, No. 20 Motion Other - Patent Owners Motion to Seal (P.T.A.B. Jul. 15, 2024)
|
|
Cite Document
14 Motion Other: Patent Owners Motion to Seal
Document
IPR2024-00631, No. 14 Motion Other - Patent Owners Motion to Seal (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
No. 29
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 29 (N.D.W.Va. May. 19, 2022)
|
|
Cite Document
No. 28
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 28 (N.D.W.Va. May. 19, 2022)
|
|
Cite Document
No. 23
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 23 (N.D.W.Va. May. 9, 2022)
|
|
Cite Document
117 Motion Other: Apotexs Motion to Expunge
Document
IPR2023-00724, No. 117 Motion Other - Apotexs Motion to Expunge (P.T.A.B. Nov. 15, 2024)
|
|
Cite Document
No. 21
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 21 (N.D.W.Va. Apr. 29, 2022)
|
|
Cite Document
No. 19
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 19 (N.D.W.Va. Apr. 8, 2022)
|
|
Cite Document
No. 12
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 12 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 10
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 10 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 9
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 9 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 11
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 11 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
